There were no significant differences between the groups in terms of age, sex or laboratory findings, but differences in log N-terminal pro-brain natriuretic peptide (NT-proBNP) and creatinine levels, bortezomib use, supportive care measures and diabetes incidence were observed (Table 1). This evidence concerns the gene NPPB and diabetes mellitus.